Cambridge Interventional LLC

Cambridge Interventional LLC manufactures radiofrequency ablation (RFA) systems for minimally invasive thermal tissue ablation across multiple organ systems. The company's flagship product, the Cambridge CRF System, is an integrated RFA platform comprising a generator-pump unit with real-time audiovisual feedback, low-profile electrodes designed to reduce hand fatigue and improve anatomical clearance, and comprehensive global training and support services. The system is indicated for ablation applications in thyroid nodules, liver tumors, renal masses, bone lesions, uterine fibroids (myomas), and lung tissue. The platform is built on over 70 years of innovation expertise and features advanced algorithms and high power output designed to enable large, controlled ablations with clinical efficacy demonstrated through long-term follow-up data. Cambridge Interventional targets interventional radiologists, endocrinologists, and other clinicians performing image-guided ablative procedures. The company actively participates in major medical society meetings including the American Thyroid Association (ATA), Western Angiographic & Interventional Society (WAIS), and American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF). The company emphasizes ease of use and clinical outcomes optimization across both experienced and novice operator profiles.